WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999042150) HEMOFILTRATION SYSTEM INCLUDING ULTRAFILTRATE PURIFICATION AND RE-INFUSION SYSTEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/042150    International Application No.:    PCT/US1999/003604
Publication Date: 26.08.1999 International Filing Date: 19.02.1999
Chapter 2 Demand Filed:    15.09.1999    
IPC:
A61M 1/34 (2006.01)
Applicants: VASCA, INC. [US/US]; Highwood Office and Research Park 3 Highwood Drive Tewksbury, MA 01876 (US)
Inventors: BURBANK, Jeffrey, H.; (US).
FINCH, C., David; (US).
BRUGGER, James, M.; (US)
Agent: RYAN, Daniel, D.; Ryan Kromholz & Manion, S.C. 633 West Wisconsin Avenue Milwaukee, WI 53203 (US)
Priority Data:
09/027,301 19.02.1998 US
Title (EN) HEMOFILTRATION SYSTEM INCLUDING ULTRAFILTRATE PURIFICATION AND RE-INFUSION SYSTEM
(FR) SYSTEME D'HEMOFILTRATION A PURIFICATION EN ULTRAFILTRATION ET REINFUSION
Abstract: front page image
(EN)A hemofiltration system (10) is provided in which ultrafiltrate is purified by reverse osmosis for reinfusion. Non-sterile infusate concentrate is dialyzed into the purified ultrafiltrate, and combined with cleared blood which is returned to the patient. In another system, a hemofilter (120) is used to sterilize essentially pure, non-sterile water for dilution of sterile infusate concentrate. The hemofilter (120) is used to filter blood, and the infusate concentrate being combined with cleared blood for return to the patient.
(FR)L'invention concerne un système (10) d'hémofiltration à purification d'ultrafiltrat par osmose inverse aux fins de réinfusion. On effectue la dialyse de concentré de soluté intraveineux non stérile dans l'ultrafiltrat purifié et, après combinaison avec du sang épuré, on procède à la réinfusion au patient. Selon une variante, un hémofiltre (120) est utilisé pour stériliser de l'eau non stérile essentiellement pure aux fins de dilution d'un concentré de soluté intraveineux stérile, puis on utilise ledit hémofiltre (120) pour filtrer le sang, et le concentré de soluté intraveineux est combiné avec du sang épuré en vue de la réinfusion au patient.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)